BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29546794)

  • 1. Corrigendum.
    J Cereb Blood Flow Metab; 2018 Jun; 38(6):119. PubMed ID: 29546794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum.
    J Cereb Blood Flow Metab; 2018 Jun; 38(6):1120. PubMed ID: 29533709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum.
    J Cereb Blood Flow Metab; 2018 May; 38(5):932. PubMed ID: 29466905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
    J Neurochem; 2017 May; 141(3):473-474. PubMed ID: 28417467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction.
    Hypertension; 2015 Dec; 66(6):e28. PubMed ID: 26558821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum.
    J Cereb Blood Flow Metab; 2018 Oct; 38(10):1848. PubMed ID: 29546778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum.
    J Cereb Blood Flow Metab; 2018 Oct; 38(10):1849. PubMed ID: 29519174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis.
    Koepp MJ; Labbé C; Richardson MP; Brooks DJ; Van Paesschen W; Cunningham VJ; Duncan JS
    Brain; 1997 Oct; 120 ( Pt 10)():1865-76. PubMed ID: 9365376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum.
    J Atten Disord; 2014 Oct; ():. PubMed ID: 25304150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum.
    Science; 1987 Feb; 235(4789):623f. PubMed ID: 17833610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy.
    Koepp MJ; Richardson MP; Labbé C; Brooks DJ; Cunningham VJ; Ashburner J; Van Paesschen W; Revesz T; Duncan JS
    Neurology; 1997 Sep; 49(3):764-73. PubMed ID: 9305338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum.
    Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1334. PubMed ID: 26510547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unified statistical approach for determining significant signals in images of cerebral activation.
    Worsley KJ; Marrett S; Neelin P; Vandal AC; Friston KJ; Evans AC
    Hum Brain Mapp; 1996; 4(1):58-73. PubMed ID: 20408186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum.
    Immunology; 2015 Oct; 146(2):347. PubMed ID: 26372102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum.
    Mult Scler; 2017 Dec; 23(14):NP1. PubMed ID: 28956510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction.
    Hypertension; 2016 Feb; 67(2):e2. PubMed ID: 26763012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal positron emission tomography imaging for monitoring myelin repair in the spinal cord.
    Wu C; Zhu J; Baeslack J; Zaremba A; Hecker J; Kraso J; Matthews PM; Miller RH; Wang Y
    Ann Neurol; 2013 Nov; 74(5):688-98. PubMed ID: 23818306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum.
    Mult Scler; 2018 Sep; 24(10):1390. PubMed ID: 29992853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.